GTBP stock forecast for 2023 – 2027
Last updated: April 24, 2024
Are you interested in GT Biopharma, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the GTBP stock price in 2022-2027. Is GTBP a good long term stock? When should I take profit in GT Biopharma stock? Buy or sell stock? Will GTBP stock price go up? What are analysts’ forecasts for GTBP stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. GTBP stock returns are also predicted based on historical data.
According to our research, GTBP stock is a awesome long-term investment. GTBP share price has been in a positive cycle for the past year. GT Biopharma, Inc. stock trend is positive.
GT Biopharma company info
| Industry | Biotechnology |
| Address | 9350 Wilshire Boulevard, Beverly Hills, CA, 90212, United States |
| Website | https://www.gtbiopharma.com |
Forecasting
52 Week High: 9.28392 USD
52 Week Low: 2.958 USD
1 Year Forecast: 8.05365 USD
5 Year Forecast: 28.031 USD
Agilent Technologies info
Market Cap: 85.02M
52 Week Change: 2.807%
52 Week High: 19.7331 USD
52 Week Low: 2.47 USD
Beta: 1.5256
50 Day Moving Average: 3.46
90 Day Moving Average: 3.815
200 Day Moving Average: 8.986
Resistance Level: 3.6006
Pivot Point: 3.0906
Support Level: 2.63
Enterprise Value: 54,979,592
Forward P/E: -2.67
Forward EPS: -1.04
Profit Margin: 0.00%
Shares Outstanding: 30,582,400
EBITDA: 0
Held Percent Institutions: 27.37%
PEG Ratio (5Y): 0
Trailing EPS: -2.244
GT Biopharma stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
GT Biopharma Stock Forecast for 2023 | |||
| January 2023 | 7 | 8 | 14.29% |
| February 2023 | 7.84 | 9 | 14.8% |
| March 2023 | 8.82 | 10.2 | 15.65% |
| April 2023 | 10 | 12.12 | 21.2% |
| May 2023 | 11.88 | 13.13 | 10.52% |
| June 2023 | 12.74 | 13.13 | 3.06% |
| July 2023 | 13.26 | 11.88 | -10.41% |
| August 2023 | 13.13 | 11.88 | -9.52% |
| September 2023 | 12.24 | 11.76 | -3.92% |
| October 2023 | 12 | 13 | 8.33% |
| November 2023 | 13.13 | 11.88 | -9.52% |
| December 2023 | 11.88 | 12.12 | 2.02% |
GT Biopharma Stock Forecast for 2024 | |||
| January 2024 | 12 | 12.87 | 7.25% |
| February 2024 | 13.13 | 14.7 | 11.96% |
| March 2024 | 15 | 15.15 | 1% |
| April 2024 | 15.15 | 17 | 12.21% |
| May 2024 | 17.34 | 17.64 | 1.73% |
| June 2024 | 17.64 | 17.82 | 1.02% |
| July 2024 | 18 | 17.82 | -1% |
| August 2024 | 17.82 | 17.34 | -2.69% |
| September 2024 | 17.17 | 17.34 | 0.99% |
| October 2024 | 16.66 | 17.64 | 5.88% |
| November 2024 | 17.82 | 16.83 | -5.56% |
| December 2024 | 16.66 | 16.66 | 0% |
GT Biopharma Stock Forecast for 2025 | |||
| January 2025 | 17.34 | 18.36 | 5.88% |
| February 2025 | 17.82 | 20 | 12.23% |
| March 2025 | 18.62 | 20.2 | 8.49% |
| April 2025 | 19.8 | 21.78 | 10% |
| May 2025 | 22 | 23.46 | 6.64% |
| June 2025 | 23 | 23.46 | 2% |
| July 2025 | 23.23 | 23.23 | 0% |
| August 2025 | 23.23 | 21.56 | -7.19% |
| September 2025 | 22.44 | 22.22 | -0.98% |
| October 2025 | 21.56 | 23.46 | 8.81% |
| November 2025 | 23.46 | 22 | -6.22% |
| December 2025 | 22 | 22.22 | 1% |
GT Biopharma Stock Forecast for 2026 | |||
| January 2026 | 22 | 23 | 4.55% |
| February 2026 | 22.54 | 25.5 | 13.13% |
| March 2026 | 23.52 | 25.25 | 7.36% |
| April 2026 | 25.5 | 27.54 | 8% |
| May 2026 | 27.54 | 27.72 | 0.65% |
| June 2026 | 28.28 | 28.56 | 0.99% |
| July 2026 | 28.28 | 27.72 | -1.98% |
| August 2026 | 27.54 | 27.27 | -0.98% |
| September 2026 | 27 | 27.54 | 2% |
| October 2026 | 27 | 27.72 | 2.67% |
| November 2026 | 27.44 | 27.54 | 0.36% |
| December 2026 | 27.54 | 27 | -1.96% |
GT Biopharma Stock Forecast for 2027 | |||
| January 2027 | 26.46 | 27.44 | 3.7% |